Hold the Presses is your online newsportal en brings press releases from around the world. Journalists can use it for free, although it is their responsibilty to check the news. Hold the Presses is in no way responsible for the content of the press releases, the Sender is. We hope you enjoy reading the news we bring you on this website. If a message is published that is not acceptable, we apologize. Please contact us and we will remove the message as soon as possible.

Friday, 29 September 2017

ESPERITE N.V. (ESP) delays publication of 2017 Interim Financial Reporting

Esperite N.V.    

Published: 21:16 CEST 29-09-2017 /GlobeNewswire /Source: Esperite N.V. / : ESP /ISIN: NL0009272137

ESPERITE N.V. (ESP) delays publication of 2017 Interim Financial Reporting

       

Zutphen, The Netherlands - 29 September 2017

 

Esperite N.V. (Euronext: ESP, the "Company" or "Esperite") announces that the Company expects to publish its Interim Financial Reporting on or before 2 October 2017.

 

 

About ESPERITE

ESPERITE Group, listed at Euronext Amsterdam and Paris, is a leading international company in regenerative and predictive medicine established in 2000.

 

***

 

This press release contains inside information as referred to in article 7 paragraph 1 of Regulation (EU) 596/2014 (Market Abuse Regulation).

 

With respect to Member States of the European Economic Area that have transposed European Directive 2003/71/EC of the European Parliament and European Council (as amended in particular by Directive 2010/73/EU to the extent that the said Directive has been transposed into each Member State of the European Economic Area), no action has been taken or will be taken to permit a public offering of the securities referred to in this press release requiring the publication of a prospectus in any Member State.

 

This press release and the information it contains do not, and will not, constitute an offer to subscribe for or sell, nor the solicitation of an offer to subscribe for or buy, securities of Esperite in the United States of America or any other jurisdiction. Securities may not be offered or sold in the United States of America absent registration or an exemption from registration under the U.S. Securities Act of 1933, as amended (the "U.S. Securities Act"), it being specified that the securities of Esperite have not been and will not be registered within the US Securities Act. Esperite does not intend to register securities or conduct a public offering in the United States of America.



ESPERITE PR delay 1HY financial reporting



This announcement is distributed by Nasdaq Corporate Solutions (One Liberty Plaza, 165 Broadway, New York, NY 10006. Tel: +1 212 401 8700. www.nasdaqomx.com) on behalf of Nasdaq Corporate Solutions clients. Source: Esperite N.V., Piet Heinstraat 11a, Zutphen 7204 JN, The Netherlands
If you would like to unsubscribe and stop receiving these e-mails click here.